Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T00140 | ||||
Target Name | Arachidonate 5-lipoxygenase (5-LOX) | ||||
Type of Target |
Successful |
||||
Drug Potency against Target | Zileuton | Drug Info | IC50 = 500~1000 nM | [13] | |
Licofelone | Drug Info | IC50 = 160 nM | [1] | ||
1,2-Dihydro-indazol-3-one | Drug Info | IC50 = 2000 nM | [3] | ||
1,2-Dihydroxy-10H-anthracen-9-one | Drug Info | IC50 = 4000 nM | [10] | ||
1,3,8-Trihydroxy-6-methyl-10H-anthracen-9-one | Drug Info | IC50 = 14000 nM | [10] | ||
1,5-Dihydroxy-10H-anthracen-9-one | Drug Info | IC50 = 10000 nM | [10] | ||
1,8,9-Trimethoxy-9,10-dihydro-anthracene | Drug Info | IC50 = 10000 nM | [10] | ||
1,8-Dichloro-10H-anthracen-9-one | Drug Info | IC50 = 4000 nM | [10] | ||
1,8-Dihydroxy-2-propionyl-10H-anthracen-9-one | Drug Info | IC50 = 6000 nM | [10] | ||
1-Benzyl-1,2-dihydro-indazol-3-one | Drug Info | IC50 = 3400 nM | [3] | ||
1-Hydroxy-10H-anthracen-9-one | Drug Info | IC50 = 13000 nM | [10] | ||
1-Hydroxy-8-methoxy-10H-anthracen-9-one | Drug Info | IC50 = 12000 nM | [10] | ||
1-Methyl-1,2-dihydro-indazol-3-one | Drug Info | IC50 = 3000 nM | [3] | ||
10-Acetyl-1,8-dihydroxy-10H-anthracen-9-one | Drug Info | IC50 = 18000 nM | [10] | ||
10-Benzoyl-1,8-dihydroxy-10H-anthracen-9-one | Drug Info | IC50 = 4000 nM | [10] | ||
2'-Nitro-biphenyl-4-carboxylic acid hydroxyamide | Drug Info | IC50 = 8300 nM | [6] | ||
2-(1H-Indol-3-ylmethyl)-1,2-dihydro-indazol-3-one | Drug Info | IC50 = 1100 nM | [3] | ||
2-(3-Phenyl-propyl)-1,2-dihydro-indazol-3-one | Drug Info | IC50 = 540 nM | [3] | ||
2-(4-Butoxy-phenoxy)-N-hydroxy-acetamide | Drug Info | IC50 = 5300 nM | [6] | ||
2-(4-Butoxy-phenoxy)-N-hydroxy-N-methyl-acetamide | Drug Info | IC50 = 890 nM | [6] | ||
2-(4-Butoxy-phenoxy)-N-hydroxy-propionamide | Drug Info | IC50 = 8060 nM | [6] | ||
2-(4-Butoxy-phenyl)-N-hydroxy-N-methyl-acetamide | Drug Info | IC50 = 720 nM | [6] | ||
2-(4-Methoxy-phenyl)-5-phenyl-thiazol-4-ol | Drug Info | IC50 = 450 nM | [4] | ||
2-(4-Phenyl-butyl)-1,2-dihydro-indazol-3-one | Drug Info | IC50 = 780 nM | [3] | ||
2-Benzyl-1,2-dihydro-indazol-3-one | Drug Info | IC50 = 360 nM | [3] | ||
2-Biphenyl-4-yl-N-hydroxy-N-methyl-acetamide | Drug Info | IC50 = 360 nM | [6] | ||
2-Furan-2-ylmethyl-1,2-dihydro-indazol-3-one | Drug Info | IC50 = 270 nM | [3] | ||
2-Methyl-1,2-dihydro-indazol-3-one | Drug Info | IC50 = 1300 nM | [3] | ||
2-Naphthalen-1-ylmethyl-1,2-dihydro-indazol-3-one | Drug Info | IC50 = 610 nM | [3] | ||
2-Naphthalen-2-ylmethyl-1,2-dihydro-indazol-3-one | Drug Info | IC50 = 970 nM | [3] | ||
2-Phenethyl-1,2-dihydro-indazol-3-one | Drug Info | IC50 = 550 nM | [3] | ||
2-Phenyl-1,2-dihydro-indazol-3-one | Drug Info | IC50 = 310 nM | [3] | ||
2-Pyridin-2-ylmethyl-1,2-dihydro-indazol-3-one | Drug Info | IC50 = 3100 nM | [3] | ||
2-Pyridin-3-ylmethyl-1,2-dihydro-indazol-3-one | Drug Info | IC50 = 1500 nM | [3] | ||
2-Pyridin-4-ylmethyl-1,2-dihydro-indazol-3-one | Drug Info | IC50 = 2400 nM | [3] | ||
2-Thiazol-5-ylmethyl-1,2-dihydro-indazol-3-one | Drug Info | IC50 = 1800 nM | [3] | ||
2-Thiophen-2-ylmethyl-1,2-dihydro-indazol-3-one | Drug Info | IC50 = 400 nM | [3] | ||
3,4-Dihydroxy-10H-anthracen-9-one | Drug Info | IC50 = 4000 nM | [10] | ||
3-(4-Butoxy-phenyl)-N-hydroxy-N-methyl-acrylamide | Drug Info | IC50 = 100 nM | [6] | ||
3-Benzoyl-N-hydroxy-benzamide | Drug Info | IC50 = 7900 nM | [6] | ||
3-Biphenyl-3-yl-N-hydroxy-N-methyl-acrylamide | Drug Info | IC50 = 70 nM | [6] | ||
3-Biphenyl-4-yl-N-hydroxy-N-methyl-acrylamide | Drug Info | IC50 = 130 nM | [6] | ||
4,5-Dihydroxy-10H-anthracen-9-one | Drug Info | IC50 = 4000 nM | [10] | ||
4,5-Dimethoxy-10H-anthracen-9-one | Drug Info | IC50 = 8000 nM | [10] | ||
4-(1H-indol-3-yl)-1-morpholinobutan-1-one | Drug Info | IC50 = 2060 nM | [2] | ||
4-Bromo-N-hydroxy-benzamide | Drug Info | IC50 = 14000 nM | [6] | ||
4-Butoxy-N-hydroxy-N-methyl-benzamide | Drug Info | IC50 = 490 nM | [6] | ||
4-Hydroxy-5-methoxy-10H-anthracen-9-one | Drug Info | IC50 = 2000 nM | [10] | ||
4-Pentadeca-1,3,6-trienylsulfanyl-butyric acid | Drug Info | IC50 = 7200 nM | [7] | ||
5,8-Dihydroxy-1,4-naphthoquinone | Drug Info | IC50 = 3000 nM | [10] | ||
5-Chloro-N-(4-ethylphenyl)benzo[d]oxazol-2-amine | Drug Info | IC50 = 950 nM | [5] | ||
5-Chloro-N-phenylbenzo[d]oxazol-2-amine | Drug Info | IC50 = 4500 nM | [5] | ||
5-Methoxy-N-phenylbenzo[d]oxazol-2-amine | Drug Info | IC50 = 7880 nM | [5] | ||
5-Methyl-2-p-tolyl-thiazol-4-ol | Drug Info | IC50 = 1200 nM | [4] | ||
5-Methyl-N-phenylbenzo[d]oxazol-2-amine | Drug Info | IC50 = 4600 nM | [5] | ||
A-78773 | Drug Info | IC50 = 298 nM | [12] | ||
Acetic acid 2-phenyl-5-propyl-thiazol-4-yl ester | Drug Info | IC50 = 660 nM | [4] | ||
Acetic acid 5-butyl-2-phenyl-thiazol-4-yl ester | Drug Info | IC50 = 500 nM | [4] | ||
Anthracene-2-carboxylic acid hydroxyamide | Drug Info | IC50 = 980 nM | [6] | ||
ANTHRONE | Drug Info | IC50 = 2000 nM | [10] | ||
Avastin+/-Tarceva | Drug Info | IC50 = 17000 nM | [10] | ||
BAICALEIN | Drug Info | IC50 = 10000 nM | [3] | ||
Biphenyl-3-carboxylic acid hydroxyamide | Drug Info | IC50 = 6000 nM | [6] | ||
Biphenyl-4-carboxylic acid hydroxyamide | Drug Info | IC50 = 4100 nM | [6] | ||
Hexanoic acid 2,5-diphenyl-thiazol-4-yl ester | Drug Info | IC50 = 500 nM | [4] | ||
Ibuproxam | Drug Info | IC50 = 4840 nM | [8] | ||
N-(2-Ethylphenyl)-5-methylbenzo[d]oxazol-2-amine | Drug Info | IC50 = 5660 nM | [5] | ||
N-(3-Bromophenyl)-5-methoxybenzo[d]oxazol-2-amine | Drug Info | IC50 = 2030 nM | [5] | ||
N-(4-Ethylphenyl)-5-methylbenzo[d]oxazol-2-amine | Drug Info | IC50 = 120 nM | [5] | ||
N-(4-Ethylphenyl)benzo[d]oxazol-2-amine | Drug Info | IC50 = 1210 nM | [5] | ||
N-Hydroxy-2-methyl-3-naphthalen-2-yl-acrylamide | Drug Info | IC50 = 1800 nM | [6] | ||
N-Hydroxy-2-naphthalen-2-yl-acetamide | Drug Info | IC50 = 19000 nM | [6] | ||
N-Hydroxy-3-naphthalen-2-yl-acrylamide | Drug Info | IC50 = 950 nM | [6] | ||
N-Hydroxy-3-naphthalen-2-yl-N-p-tolyl-acrylamide | Drug Info | IC50 = 280 nM | [6] | ||
N-Hydroxy-3-naphthalen-2-yl-N-phenyl-acrylamide | Drug Info | IC50 = 52 nM | [6] | ||
N-Hydroxy-3-naphthalen-2-yl-propionamide | Drug Info | IC50 = 9700 nM | [6] | ||
N-Hydroxy-3-phenyl-acrylamide | Drug Info | IC50 = 12000 nM | [6] | ||
N-hydroxy-4-(naphthalen-1-yl)benzamide | Drug Info | IC50 = 180 nM | [6] | ||
N-Hydroxy-4-iodo-benzamide | Drug Info | IC50 = 15000 nM | [6] | ||
N-Hydroxy-4-isobutyl-benzamide | Drug Info | IC50 = 6000 nM | [6] | ||
N-Hydroxy-4-naphthalen-2-yl-benzamide | Drug Info | IC50 = 330 nM | [6] | ||
N-Hydroxy-N-methyl-2,3,3-triphenyl-acrylamide | Drug Info | IC50 = 2700 nM | [6] | ||
N-Hydroxy-N-methyl-2-naphthalen-2-yl-propionamide | Drug Info | IC50 = 590 nM | [6] | ||
N-Hydroxy-N-methyl-3-naphthalen-1-yl-acrylamide | Drug Info | IC50 = 210 nM | [6] | ||
N-Hydroxy-N-methyl-3-naphthalen-2-yl-acrylamide | Drug Info | IC50 = 100 nM | [8] | ||
N-Hydroxy-N-methyl-3-naphthalen-2-yl-propionamide | Drug Info | IC50 = 380 nM | [6] | ||
N-Hydroxy-N-methyl-3-phenanthren-2-yl-acrylamide | Drug Info | IC50 = 130 nM | [6] | ||
N-Hydroxy-N-methyl-3-phenanthren-3-yl-acrylamide | Drug Info | IC50 = 100 nM | [6] | ||
N-Hydroxy-N-methyl-3-phenanthren-9-yl-acrylamide | Drug Info | IC50 = 120 nM | [6] | ||
N-Hydroxy-N-methyl-benzamide | Drug Info | IC50 = 14000 nM | [6] | ||
N-hydroxy-N-[1-(4-isobutylphenyl)ethyl]urea | Drug Info | IC50 = 600 nM | [9] | ||
N-Phenylbenzo[d]oxazol-2-amine | Drug Info | IC50 = 8910 nM | [5] | ||
NAFAZATROM | Drug Info | IC50 = 6000 nM | [7] | ||
Naphthalene-2-carboxylic acid hydroxyamide | Drug Info | IC50 = 14000 nM | [6] | ||
Phenanthrene-2-carboxylic acid hydroxyamide | Drug Info | IC50 = 1900 nM | [6] | ||
Phenanthrene-3-carboxylic acid hydroxyamide | Drug Info | IC50 = 1200 nM | [6] | ||
PYROGALLOL | Drug Info | IC50 = 4000 nM | [10] | ||
REV-5901 | Drug Info | IC50 = 3000 nM | [3] | ||
TEBUFELONE | Drug Info | IC50 = 3000 nM | [11] | ||
TZI-41127 | Drug Info | IC50 = 110 nM | |||
References | |||||
REF 1 | Designed multiple ligands. An emerging drug discovery paradigm. J Med Chem. 2005 Oct 20;48(21):6523-43. | ||||
REF 2 | Indole derivatives as potent inhibitors of 5-lipoxygenase: design, synthesis, biological evaluation, and molecular modeling. Bioorg Med Chem Lett. 2007 May 1;17(9):2414-20. | ||||
REF 3 | Indazolinones, a new series of redox-active 5-lipoxygenase inhibitors with built-in selectivity and oral activity. J Med Chem. 1991 Mar;34(3):1028-36. | ||||
REF 4 | 4-hydroxythiazole inhibitors of 5-lipoxygenase. J Med Chem. 1991 Jul;34(7):2158-65. | ||||
REF 5 | Synthesis and evaluation of benzoxazole derivatives as 5-lipoxygenase inhibitors. Bioorg Med Chem. 2010 Nov 1;18(21):7580-5. | ||||
REF 6 | Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships. J Med Chem. 1990 Mar;33(3):992-8. | ||||
REF 7 | Design, synthesis, and 5-lipoxygenase-inhibiting properties of 1-thio-substituted butadienes. J Med Chem. 1990 Apr;33(4):1163-70. | ||||
REF 8 | In vivo characterization of hydroxamic acid inhibitors of 5-lipoxygenase. J Med Chem. 1987 Nov;30(11):2121-6. | ||||
REF 9 | Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitors. J Med Chem. 1997 Feb 28;40(5):819-24. | ||||
REF 10 | Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity. J Med Chem. 1997 Nov 7;40(23):3773-80. | ||||
REF 11 | New cyclooxygenase-2/5-lipoxygenase inhibitors. 2. 7-tert-butyl-2,3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflamm... J Med Chem. 1998 Mar 26;41(7):1124-37. | ||||
REF 12 | (+/-)-trans-2-[3-methoxy-4-(4-chlorophenylthioethoxy)-5-(N-methyl-N- hydroxyureidyl)methylphenyl]-5-(3,4, 5-trimethoxyphenyl)tetrahydrofuran (CMI-3... J Med Chem. 1998 May 21;41(11):1970-9. | ||||
REF 13 | Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. Biochem Pharmacol. 2002 Dec 15;64(12):1767-75. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.